chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ight-headed; listless; tired; headache; injection site soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired), HEADACHE (headache), INJECTION SITE PAIN (injection site soreness), DIZZINESS (ight-headed) and LISTLESS (listless) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     The patient's past medical history included Pneumonia. Concomitant products included LISINOPRIL for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced FATIGUE (tired), HEADACHE (headache), INJECTION SITE PAIN (injection site soreness) and LISTLESS (listless). On 23-Feb-2021, the patient experienced DIZZINESS (ight-headed). On 19-Feb-2021, INJECTION SITE PAIN (injection site soreness) had resolved. On 20-Feb-2021, FATIGUE (tired), HEADACHE (headache) and LISTLESS (listless) had resolved. At the time of the report, DIZZINESS (ight-headed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment included Tylenol; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Headache, injection site pain and fatigue are consistent with the known safety profile of mRNA-1273
booster shot; vomiting; fever of a hundred degrees; mouth pain in my gums; canker sore; body aches; swelling in my arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administration date 13Nov2021 (Lot number: ff2590) at the age of 50 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), when the patient was 50 years old, for COVID-19 immunization; Bnt162b2 (Dose: 2), when the patient was 50 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 13Nov2021, outcome "unknown", described as "booster shot"; VOMITING (non-serious) with onset 13Nov2021, outcome "unknown", described as "vomiting"; PYREXIA (non-serious) with onset 13Nov2021, outcome "unknown", described as "fever of a hundred degrees"; GINGIVAL PAIN (non-serious) with onset 13Nov2021, outcome "unknown", described as "mouth pain in my gums"; APHTHOUS ULCER (non-serious) with onset 13Nov2021, outcome "unknown", described as "canker sore"; PAIN (non-serious) with onset 13Nov2021, outcome "unknown", described as "body aches"; PERIPHERAL SWELLING (non-serious) with onset 13Nov2021, outcome "unknown", described as "swelling in my arm". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient started having side effects about sixteen hours after the booster shot.  Follow-up attempts are completed. No further information is expected.
Wrong pfizer vaccine adminstered. Patient was given Pfizer for ages 5-11.  Physician and mother notified. Physician recommended additional 0.1ml of Pfizer 5-11 be adminstered.
19Feb98 pt recv 1dose vax. 21Feb98 pt exp approx 15 lesions on trunk & face and 101 temp.
large, red rash at injection site.  Raised and itchy, no painful.  Gradually declined, red area still evident on 10/29/22
1/13/14 10:45 AM GARDASIL given. 1/14/14 7:30 AM c/o severe headaches, nausea, slight dizziness and "teeth hurt". All tests and physical exam normal. Continue MOTRIN, light diet and rest. Advised not to complete GARDASIL. Also fever 102 degrees by that afternoon - 1/14/14.
An expired PROQUAD administered to a patient; This spontaneous report has been received from a nurse, reporting to a patient of unknown age and gender. Information regarding medical history, concurrent conditions or concomitant medication was not provided.  On 12-OCT-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) lot # S008578, expiration date 16-SEP-2020, dose: 0.5 milliliter for prophylaxis (route and site of administration not reported) (expired product administered).
10 days after the first dose, there was an injection site reaction. The area was red (size of 2 half dollars) and slighty itchy. No medication  was taken. On April 23, the area was no longer itchy but still discolored (a few shades darker than the patient's skin color - like a bad tan)
Pregnant at time of vaccination Z34.90 - Encounter for elective induction of labor O32.1XX0 - Maternal care for breech presentation, not applicable or unspecified
loose stools/diarrheas, headache, tired, nausea, arm soreness, body aches,
At the end of 2018 and first of 2019, the patient received the first two doses of RabAvert and did not come back; Case reference number US-BN-2022-001120 is a spontaneous case report initially received on 23-May-2022 from other health professional via Communication (reference number: USBAV22-0215) and concerns a 42-year-old male patient.  The patient's medical history and concomitant medication details were not provided.  On unspecified dates in 2018 and 2019, the patient received the first and the second dose of RabAvert (Rabies Virus (Inactivated, Strain Flury LEP) (PCEC), batch numbers were not provided), at dose reported as 'one vaccine per dose', at an unknown route and site of administration for pre-exposure immunization.   As reported, the patient did not come back to get anymore (explicitly coded as *'incomplete course of vaccination'*), and now he called and wanted to finish the series.   At the time of this report, it was unknown whether the patient experienced any adverse events from the vaccine.   All updated information is blended into the case narrative above, with the corrected information presented between asterisks (*).  Need for significant case correction identified on 13-Jun-2022 for the information received on 23-May-2022, included recoding of the event (from 'missed dose' to 'incomplete course of vaccination').; Reporter's Comments: A 42-year-old male patient received the first and the second dose of RabAvert for pre exposure immunization, on unspecified dates in 2018 and 2019, and reportedly, the patient did not come back to get anymore, which is considered as incomplete course of vaccination. It was unknown whether the patient experienced any adverse events from the vaccine with the reported medication error. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incomplete course of vaccination has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 42-year-old male patient received the first and the second dose of RabAvert for pre exposure immunization, on unspecified dates in 2018 and 2019, and reportedly, the patient did not come back to get anymore, which is considered as incomplete course of vaccination. It was unknown whether the patient experienced any adverse events from the vaccine with the reported medication error. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incomplete course of vaccination has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Patient admitted to Medical And Oncology on 1/31/22 from Emergency Services with increased shortness of breath, increased edema, hypoxia.  Tested positive for COVID on 2/2/22.
I experienced sudden onset of fever, chills, severe body aches, severe headache, jaw pain, head pain, and fatigue.  Fever and chills lasted 6 hours.  Body aches and fatigue lasted 24 hours.  Headache lasted 72 hours.  I took Tylenol for all of the symptoms.
red rimmed area-blanches easy to touch;14cm x 9cm little swelling;indurated (robin egg) area around inj site;itches, hurt 1-2 p/vax (days);
Per telephone call, uncle reports that on Sun. 04/20/2003-child complained of pimple itching.  On 04/22/2003 when uncle called states that "pimple-like lesions erupted mainly on torso."  States < 10 lesions on body.  Denies evaluated temp or malaise.
A fever in the arm that started the evening after injection. Been only using cold compressions. Then today a rash developed.
Injection 6/28 pm. (L) arm subsequently swelled/red. No constitutional signs reported. Pt declined consultation in office. Got PREVNAR in 2015.
This spontaneous report as received from a pharmacist refers to an 85 year old female patient with no known relevant medical history or drug allergy. On 03-MAY-2013 the patient was vaccinated with ZOSTAVAX (lot # H019040, expiry date 17-JAN-2014), 0.65 ml, subcutaneous. Concomitant therapies included omeprazole(manufacturer unknown) and lisinopril(manufacturer unknown). Approximately 2 days later (05-MAY-2013) the patient experienced mild itching at the injection site. Pharmacist inspected patient's arm and there was hotness at the injection site but there was no rash, no redness and no swelling. Patient did not seek medical attention. No lab test done. Patient has applied ice to the area of the injection in an attempt to cool the area down. At the time of reporting the events persisted. Additional information has been requested.
facial numbness & tingling/ my right fingertips went numb; facial numbness & tingling; my face & lips felt like they had been shot full of novocaine.; my hot flashes came back; loss of taste in the right side of my mouth.; The numbness in my fingers went away; This is a spontaneous report from a contactable consumer. A 60 year old female patient received second dose of bnt162b2 (COMIRNATY solution for injection, Batch/Lot Number: GN6204) via an unspecified route of administration, administered in Arm Left on 8Mar2021 04:00 PM as dose 2, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included high blood pressure from an unknown date and unknown if ongoing and allergic reaction to sulpha drugs from an unknown date and was unknown if ongoing. Concomitant medications included hydrochlorothiazide, lisinopril (LISINOPRIL HCTZ)  taken for an unspecified indication, start and stop date were not reported. The patient experienced right fingertips went numb, the lower, right quadrant of face & lips felt like they had been shot full of novocaine, hot flashes came back (but only to face) with a vengeance, the numbness in fingers went away, facial numbness & tingling and loss of taste in the right side of mouth on 10Mar2021. Patient did not receive treatment for these events. Patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient reported that 2 days after 2nd dose of the vaccine, patients' right fingertips went numb. The lower, right quadrant of her face & lips felt like they had been shot full of novocaine. And, after 2 years, her hot flashes came back (but only to her face) with a vengance. The numbness in her fingers went away, but the patient is still plagued by the facial numbness & tingling and loss of taste in the right side of mouth. And, the severity of the hot flashes has increased. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The most recent COVID-19 vaccine was administered at Workplace clinic. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The clinical outcome of the event numbness in fingers was recovered and of other events was not recovered.  No follow-up attempts are possible; No further information is expected  Follow-Up (11Aug2021): Follow-up attempts are completed. No further information is expected.
Presented with non-productive cough x1 day, hyperglycemia; + covid in ED: Admit 9/26 to tele with covid PNA, hyperglycemia; Tx with singulair, zinc starting on 9/26; primarily treated for hyperglycemia; O2  at RA throughout stay
This spontaneous report as received from a physician via company representative refers to a 15 year old male patient. On 02-DEC-2014 the patient was vaccinated with GARDASIL (dose 1; route and dosage unknown; lot number reported as K0006124). Concomitant vaccine, administered on the same date included FLUMIST. The patient initially did not have any adverse reactions. However, four to five hours later, when the patient was at school, he fell to this knees and then fell backwards and hit his head "sustaining a concussion". The patient had psychiatric and neurologic issues that are ongoing. The patient was "being followed closely by a neurologist and a psychiatrist". The reporter believed the patient's parents were given a "consult" with a division for infectious diseases. The patient sought unspecified medical attention. The outcome of hit his head "sustaining concussion" and he fell to his knee and then fell backwards was unknown. The outcome of the patient had neurologic issues and the patient had psychiatric issues was reported as not recovered. Lot number K0006124 is an invalid lot number for GARDASIL. Additional information has been requested.
First dose of Moderna was administered to a 16 year old.  No adverse effects reported or observed.
No adverse reactions at this time -filled out form because pt was given 0.3 mls of undiluted pediatric orange vial not rtu gray vial -pt received dose of 30 mcg.
Child received IZ on 6/19/00. Mother telephoned on 6/21/00 and reported that child had temperature and was managed with Tylenol. He developed small fluid (clear) filled blisters on his legs since this morning with itching. No hives. On 6/22/00, follow-up phone call to mother, indicates rash no worse and temperature is resolved. Itching was controlled with OTC "steroid" cream.
Its not just the pain where the shot is at, its the pain all over my arm including in my fingers and all the way to my back and neck/Leg pain; Its not just the pain where the shot is at, its the pain all over my arm including in my fingers and all the way to my back and neck; Its not just the pain where the shot is at, its the pain all over my arm including in my fingers and all the way to my back and neck; nerve damage/ veins in my arm are severely damaged; I have to have someone over here to help me do almost everything; uncomfortable; Migraine headache; I can't stand in any light or noise or anything; I can't stand in any light or noise or anything; I am not really well; light headed; This is a spontaneous report received from a contactable consumer or other non hcp. A female patient of an unspecified age received 2nd dose of bnt162b2 (Pfizer-Biontech Covid19 vaccine,Batch/Lot Number: EW0187), via an unspecified route of administration, administered in Arm Right on 21May2021 as DOSE 2,single for covid-19 immunization.Medical history included asthma from an unknown date and unknown if ongoing Verbatim:Asthma.Concomitant medication(s) included albuterol sulfate taken for asthma, start and stop date were not reported.The patient experienced its not just the pain where the shot is at, its the pain all over my arm including in my fingers and all the way to my back and neck/leg pain, nerve damage/ veins in my arm are severely damaged , i have to have someone over here to help me do almost everything, uncomfortable, migraine headache, i can't stand in any light or noise or anything, i can't stand in any light or noise or anything, i am not really well and light headed on 2021.Therapeutic measures were taken as a result of its not just the pain where the shot is at, its the pain all over my arm including in my fingers and all the way to my back and neck/leg pain,its not just the pain where the shot is at, its the pain all over my arm including in my fingers and all the way to my back and neck,its not just the pain where the shot is at, its the pain all over my arm including in my fingers and all the way to my back and neck.pain medication which are Tylenol #4 (treatment) and patient take the 1 every 8 hours. Tylenol #4 I take 1 tablet by mouth every 6 hours as needed for pain.The outcome of the events was unknown.The patient previously received her 1st dose of Pfizer covid vaccine on 29Apr2021,lot number EW0167.  Follow up(17Sep2021):The patient therapy for pain was updated and patient took 1 pill every 8 hours tyenol.Lot number of 2 doses vaccine was updated to be EW0167 and EW0187. Follow-Up (22Sep2021): Follow-up attempts are completed. No further information is expected.
Pt exp swelling, redness, & pain @ inject site immediately p/receiving Td;
Fell last night; Doesn't feel strength on his legs and arms; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell last night) and ASTHENIA (Doesn't feel strength on his legs and arms) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced FALL (Fell last night) and ASTHENIA (Doesn't feel strength on his legs and arms). At the time of the report, FALL (Fell last night) and ASTHENIA (Doesn't feel strength on his legs and arms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       After receiving vaccine, the patient fell down and doesn't have strength on his legs and arms. Now the patient is walking with the help of a walker.  Concomitant medications were not reported.  No treatment details were provided; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
I experienced a Miscarriage 03/22/2021 at five weeks pregnancy. I had gotten the second dose of the vaccine eight weeks before that.  I was unaware that I was pregnant when I miscarried. I only found out I was pregnant four days before it happened.  Due Date-09/18/2021 Pregnancy-Third
Patient received a Moderna vaccination one day past its BUD in the fridge. Moderna contacted and stated no need for revaccination. No reported adverse events from patient.
No adverse events were reported after dose 1 and dose 2 of DTaP. On 03/21/01, the vaccinee received his third IM dose of DTaP, his second IM dose of Hemophilus b conjugate and Hepatitis B (recombinant) vaccine and his third IM dose of Prevnar. On 03/22/92, he experienced "severe" and generalized urticaria. On 03/22/01, he started treatment with Benadryl every 6 to 8 hours orally for hives. The urticaria resolved on 04/05/01, at which time the Benadryl treatment was stopped and DTaP was discontinued. The reporting physician stated that the adverse event was possibly related to the DTaP. As of 04/24/01, the outcome of the event was resolved
Has progressed since shot into extreme debilitating tinnitus, partial hearing loss, head pain and pressure.
Injection site pain and inflammation on 7-8 September 2021, four months after receiving second dose of vaccine. Had very mild pain during first injection that lasted less than 5 minutes and no pain with second injection. Woke up from sleep on 7 September with similar pain as experienced after first injection but much stronger, accompanied with swelling. Pain increased with movement of arm and movement was limited. Responds well to ibuprofen and but has persisted for two days and required frequent re-dosing of ibuprofen.  Severe enough to impact daily activities but not severe enough to seek further medical attention.
Per mother's report patient had a febrile seizure the following day after her vaccine. She was brought to the ER and treated for dehydration.
Red; Lump; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red), VACCINATION SITE MASS (Lump) and VACCINATION SITE PAIN (arm pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red), VACCINATION SITE MASS (Lump) and VACCINATION SITE PAIN (arm pain). At the time of the report, ERYTHEMA (Red), VACCINATION SITE MASS (Lump) and VACCINATION SITE PAIN (arm pain) outcome was unknown.            No concomitant medication reported. No treatment medication reported.   This case was linked to MOD-2021-328266, MOD-2021-328332 (Patient Link).   Reporter did not allow further contact
2wk p/vax pt woke up blind in one eye;3MAR97 pt presented to MD w/eye c/o;MD noted pt had corneal abnormality on lt eye;17MAR97 pt seen by MD dx keratoconus;lt hypertropia & extropia;irregular astigmatism;elevation temporally eye;
Severe redness, warmth, itching swelling (R) upper arm shoulder and lymphadenopathy (R) supraclavicular and (R) axillary within 24-48 hours of vaccination. No SOB.
Chills; Fatigue; Bell's palsy; A spontaneous report was received from a 49-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chills and bell's palsy.  The patient's medical history was not provided.  Concomitant medications include daily vitamin.  On 15-JAN-2021, prior to the onset of the events the patient received her first of two planned doses of mRNA-1273 (lot/batch: 037K20A) intramuscularly for prophylaxis of COVID-19 infection. A few hours after receiving  the Covid-19 vaccine, the patient had chills for a day. On 08-FEB-2021, 25 days after receiving the vaccine, the patient experienced bell's palsy on her left side of the face. On 12-FEB-2021, the patient received her second of two planned doses of mRNA-1273 (lot/batch: 043L20A) intramuscularly on left arm for prophylaxis of COVID-19 infection.  Treatment details were not provided.  Action taken with mRNA-1273 in response to the events was not applicable as the patient already received the second dose of the vaccine.   The outcome of event(s), chills was recovered and the outcome for the event bell's palsy was not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.